Xencor reported $857.92M in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Abbvie ABBV:US $ 143211M 3318M
Alnylam Pharmaceuticals ALNY:US $ 3433.54M 209.76M
Amgen AMGN:US $ 59196M 1969M
Arrowhead Research ARWR:US $ 703.58M 65.04M
AstraZeneca AZN:LN 100273M 5090M
Biogen BIIB:US $ 23614.4M 262.9M
Bristol Myers Squibb BMY:US $ 103034M 6280M
Cytokinetics CYTK:US $ 856.25M 14.93M
Epizyme EPZM:US $ 312.19M 23.19M
GlaxoSmithKline GSK:LN 89689M 10586M
Johnson & Johnson JNJ:US $ 178355M 3663M
Karyopharm Therapeutics KPTI:US $ 294.03M 11.27M
Macrogenics MGNX:US $ 271.44M 63.8M
Merk MRK:US $ 106668M 974M
Novartis NOVN:VX SF 125218M 6577M
Regeneron Pharmaceuticals REGN:US $ 26348.7M 913.9M
Seattle Genetics SGEN:US $ 3616.69M 102.91M
Xencor XNCR:US $ 857.92M 19.71M